60 related articles for article (PubMed ID: 38739269)
1. Pan-cancer analysis of CDKN2A alterations identifies a subset of gastric cancer with a cold tumor immune microenvironment.
Deng C; Li ZX; Xie CJ; Zhang QL; Hu BS; Wang MD; Mei J; Yang C; Zhong Z; Wang KW
Hum Genomics; 2024 May; 18(1):55. PubMed ID: 38822443
[TBL] [Abstract][Full Text] [Related]
2. HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study.
Naranbhai V; Viard M; Dean M; Groha S; Braun DA; Labaki C; Shukla SA; Yuki Y; Shah P; Chin K; Wind-Rotolo M; Mu XJ; Robbins PB; Gusev A; Choueiri TK; Gulley JL; Carrington M
Lancet Oncol; 2022 Jan; 23(1):172-184. PubMed ID: 34895481
[TBL] [Abstract][Full Text] [Related]
3. PTCH1 mutation as a potential predictive biomarker for immune checkpoint inhibitors in gastrointestinal cancer.
Deng S; Gu H; Chen Z; Liu Y; Zhang Q; Chen D; Yi S
Carcinogenesis; 2024 May; 45(5):351-357. PubMed ID: 38310539
[TBL] [Abstract][Full Text] [Related]
4. Identification of ATM Mutation as a Potential Prognostic Biomarker for Immune Checkpoint Inhibitors Therapy.
Cui S; Chen T; Zhao Y; Xiao Z; Liu M; Huang X; Cao S; Zhou R; Li Y; Huo X; Wang N
Curr Cancer Drug Targets; 2024; 24(5):501-509. PubMed ID: 38804343
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and advantage of immunotherapy for melanoma
Yang Y; Huang Q; Cheng M; Deng L; Liu X; Zheng X; Wei J; Lei Y; Li X; Guo F; Deng Y; Zheng Y; Bi F; Wang G; Liu M
Am J Cancer Res; 2024; 14(5):2626-2642. PubMed ID: 38859854
[TBL] [Abstract][Full Text] [Related]
6. ICI efficacy information portal: a knowledgebase for responder prediction to immune checkpoint inhibitors.
Chen J; Rebibo D; Cao J; Mok SY; Patel N; Tseng PC; Zhang Z; Yip KY
NAR Cancer; 2023 Mar; 5(1):zcad012. PubMed ID: 36879684
[TBL] [Abstract][Full Text] [Related]
7. PCDH11X mutation as a potential biomarker for immune checkpoint therapies in lung adenocarcinoma.
Liu M; Yang M; Zhang B; Xia S; Zhao J; Yan L; Ren Y; Guo H; Zhao J
J Mol Med (Berl); 2024 May; ():. PubMed ID: 38739269
[TBL] [Abstract][Full Text] [Related]
8. Integrative analysis of potential diagnostic markers and therapeutic targets for glomerulus-associated diabetic nephropathy based on cellular senescence.
Sun D; Wei S; Wang D; Zeng M; Mo Y; Li H; Liang C; Li L; Zhang JW; Wang L
Front Immunol; 2023; 14():1328757. PubMed ID: 38390397
[TBL] [Abstract][Full Text] [Related]
9. CD300ld on neutrophils is required for tumour-driven immune suppression.
Wang C; Zheng X; Zhang J; Jiang X; Wang J; Li Y; Li X; Shen G; Peng J; Zheng P; Gu Y; Chen J; Lin M; Deng C; Gao H; Lu Z; Zhao Y; Luo M
Nature; 2023 Sep; 621(7980):830-839. PubMed ID: 37674079
[TBL] [Abstract][Full Text] [Related]
10. The global burden of lung cancer: current status and future trends.
Leiter A; Veluswamy RR; Wisnivesky JP
Nat Rev Clin Oncol; 2023 Sep; 20(9):624-639. PubMed ID: 37479810
[TBL] [Abstract][Full Text] [Related]
11. Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer.
Ravi A; Hellmann MD; Arniella MB; Holton M; Freeman SS; Naranbhai V; Stewart C; Leshchiner I; Kim J; Akiyama Y; Griffin AT; Vokes NI; Sakhi M; Kamesan V; Rizvi H; Ricciuti B; Forde PM; Anagnostou V; Riess JW; Gibbons DL; Pennell NA; Velcheti V; Digumarthy SR; Mino-Kenudson M; Califano A; Heymach JV; Herbst RS; Brahmer JR; Schalper KA; Velculescu VE; Henick BS; Rizvi N; Jänne PA; Awad MM; Chow A; Greenbaum BD; Luksza M; Shaw AT; Wolchok J; Hacohen N; Getz G; Gainor JF
Nat Genet; 2023 May; 55(5):807-819. PubMed ID: 37024582
[TBL] [Abstract][Full Text] [Related]
12. Macrophage elastase derived from adventitial macrophages modulates aortic remodeling.
Chen Y; Yang X; Kitajima S; Quan L; Wang Y; Zhu M; Liu E; Lai L; Yan H; Fan J
Front Cell Dev Biol; 2022; 10():1097137. PubMed ID: 36704203
[TBL] [Abstract][Full Text] [Related]
13. The Predictive Value of PAK7 Mutation for Immune Checkpoint Inhibitors Therapy in Non-Small Cell Cancer.
Zeng H; Tong F; Bin Y; Peng L; Gao X; Xia X; Yi X; Dong X
Front Immunol; 2022; 13():834142. PubMed ID: 35242138
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and Immunological Role of FAT Family Genes in Non-Small Cell Lung Cancer.
Feng Z; Yin Y; Liu B; Zheng Y; Shi D; Zhang H; Qin J
Cancer Control; 2022; 29():10732748221076682. PubMed ID: 35212236
[TBL] [Abstract][Full Text] [Related]
15. A mutation-based gene set predicts survival benefit after immunotherapy across multiple cancers and reveals the immune response landscape.
Long J; Wang D; Wang A; Chen P; Lin Y; Bian J; Yang X; Zheng M; Zhang H; Zheng Y; Sang X; Zhao H
Genome Med; 2022 Feb; 14(1):20. PubMed ID: 35197093
[TBL] [Abstract][Full Text] [Related]
16. Tumor-Associated Regulatory T Cell Expression of LAIR2 Is Prognostic in Lung Adenocarcinoma.
Ly D; Li Q; Navab R; Zeltz C; Fang L; Cabanero M; Zhu CQ; Tsao MS; Zhang L
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008369
[TBL] [Abstract][Full Text] [Related]
17. Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma.
Nie M; Yao K; Zhu X; Chen N; Xiao N; Wang Y; Peng B; Yao L; Li P; Zhang P; Hu Z
Nat Commun; 2021 Nov; 12(1):6479. PubMed ID: 34759281
[TBL] [Abstract][Full Text] [Related]
18. Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy.
Jiang M; Jia K; Wang L; Li W; Chen B; Liu Y; Wang H; Zhao S; He Y; Zhou C
Acta Pharm Sin B; 2021 Oct; 11(10):2983-2994. PubMed ID: 34729299
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
